PHI with Hashimoto's thyroiditis

How does this condition affect your private health insurance?

Hashimoto's thyroiditis is an autoimmune disorder where the immune system mistakenly attacks and gradually destroys the thyroid gland. This chronic inflammation typically leads to hypothyroidism, characterized by insufficient thyroid hormone production. Symptoms often develop slowly over years, including fatigue, weight gain, cold intolerance, dry skin, hair loss, and depression. Diagnosis involves detecting elevated TSH, low free T4, and high levels of anti-thyroid peroxidase (anti-TPO) antibodies. More prevalent in women, it often has a genetic predisposition. Although there is no cure, treatment involves lifelong daily thyroid hormone replacement therapy (levothyroxine) to restore normal hormone levels, alleviate symptoms, and prevent complications. Regular monitoring is essential for dosage adjustments.

PKV Risk Assessment

High Probability of Rejection

However, some specialized PHI providers may insure you with a surcharge of up to 20%.

This is a preliminary assessment. For a detailed and binding risk assessment, .

Impact on Your Insurance Policy

Duration of Illness (Initial)

Gradual onset over months to years, often asymptomatic until significant thyroid damage occurs.

Duration of Illness (Lifetime)

Lifelong, as it is an autoimmune disease requiring continuous management.

Cost of Treatment (Initial)

Moderate (diagnosis including blood tests and initial specialist consultation, plus initial medication supply).

Cost of Treatment (Lifetime)

High (lifelong medication, regular blood tests, and specialist follow-ups).

Mortality Rate

Very low, almost negligible if adequately managed with thyroid hormone replacement therapy.

Risk of Secondary Damages

Moderate (increased risk of other autoimmune diseases, cardiovascular complications if hypothyroidism is severe and untreated; potential for cognitive effects and infertility if poorly managed).

Probability of Full Recovery

Very low, as it is a chronic autoimmune disease; treatment manages symptoms but does not cure the underlying condition.

Underlying Disease Risk

Moderate (increased association with other autoimmune conditions such as celiac disease, type 1 diabetes, rheumatoid arthritis, pernicious anemia, and vitiligo).

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.